SCLX
Price
$4.82
Change
-$0.37 (-7.13%)
Updated
Jun 13 closing price
Capitalization
165.55M
SNYNF
Price
$99.50
Change
-$2.07 (-2.04%)
Updated
Jun 13 closing price
Capitalization
134.16B
Interact to see
Advertisement

SCLX vs SNYNF

Header iconSCLX vs SNYNF Comparison
Open Charts SCLX vs SNYNFBanner chart's image
Scilex Holding
Price$4.82
Change-$0.37 (-7.13%)
Volume$140.97K
Capitalization165.55M
Sanofi
Price$99.50
Change-$2.07 (-2.04%)
Volume$136.31K
Capitalization134.16B
SCLX vs SNYNF Comparison Chart
Loading...
SCLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SCLX vs. SNYNF commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCLX is a Buy and SNYNF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (SCLX: $4.82 vs. SNYNF: $99.50)
Brand notoriety: SCLX and SNYNF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: SCLX: 84% vs. SNYNF: 395%
Market capitalization -- SCLX: $165.55M vs. SNYNF: $134.16B
SCLX [@Pharmaceuticals: Major] is valued at $165.55M. SNYNF’s [@Pharmaceuticals: Major] market capitalization is $134.16B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SCLX’s FA Score shows that 0 FA rating(s) are green whileSNYNF’s FA Score has 1 green FA rating(s).

  • SCLX’s FA Score: 0 green, 5 red.
  • SNYNF’s FA Score: 1 green, 4 red.
According to our system of comparison, SNYNF is a better buy in the long-term than SCLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SCLX’s TA Score shows that 4 TA indicator(s) are bullish.

  • SCLX’s TA Score: 4 bullish, 5 bearish.

Price Growth

SCLX (@Pharmaceuticals: Major) experienced а -23.61% price change this week, while SNYNF (@Pharmaceuticals: Major) price change was -3.40% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.11%. For the same industry, the average monthly price growth was +8.48%, and the average quarterly price growth was +9.89%.

Industries' Descriptions

@Pharmaceuticals: Major (+1.11% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNYNF($134B) has a higher market cap than SCLX($166M). SNYNF YTD gains are higher at: 4.627 vs. SCLX (-67.703). SNYNF has higher annual earnings (EBITDA): 13.8B vs. SCLX (-109.1M). SNYNF has more cash in the bank: 7.99B vs. SCLX (3.92M). SCLX has less debt than SNYNF: SCLX (128M) vs SNYNF (21B). SNYNF has higher revenues than SCLX: SNYNF (46.1B) vs SCLX (46.7M).
SCLXSNYNFSCLX / SNYNF
Capitalization166M134B0%
EBITDA-109.1M13.8B-1%
Gain YTD-67.7034.627-1,463%
P/E RatioN/A14.04-
Revenue46.7M46.1B0%
Total Cash3.92M7.99B0%
Total Debt128M21B1%
FUNDAMENTALS RATINGS
SNYNF: Fundamental Ratings
SNYNF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
96
SMR RATING
1..100
75
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SCLX
RSI
ODDS (%)
Bearish Trend 4 days ago
36%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
53%
Momentum
ODDS (%)
Bearish Trend 4 days ago
49%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
31%
Advances
ODDS (%)
Bullish Trend 20 days ago
69%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
39%
Aroon
ODDS (%)
Bullish Trend 4 days ago
22%
View a ticker or compare two or three
Interact to see
Advertisement
SCLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGIRX15.58-0.12
-0.76%
Virtus Duff & Phelps Global Infras R6
SVBIX29.46-0.23
-0.77%
JHancock Balanced I
FIVVX34.38-0.44
-1.26%
Macquarie Opportunity R6
TISDX11.82-0.17
-1.42%
Transamerica Intl Sust Eq A
CLCRX22.04-0.69
-3.03%
Columbia Select Large Cap Equity Inst2

SCLX and

Correlation & Price change

A.I.dvisor tells us that SCLX and CSWYF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCLX and CSWYF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCLX
1D Price
Change %
SCLX100%
-7.13%
CSWYF - SCLX
24%
Poorly correlated
N/A
BIIB - SCLX
21%
Poorly correlated
-1.25%
AMRN - SCLX
21%
Poorly correlated
-0.97%
PFE - SCLX
14%
Poorly correlated
-1.21%
ABBV - SCLX
13%
Poorly correlated
-0.70%
More

SNYNF and

Correlation & Price change

A.I.dvisor tells us that SNYNF and NVSEF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNYNF and NVSEF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNYNF
1D Price
Change %
SNYNF100%
-2.04%
NVSEF - SNYNF
27%
Poorly correlated
+1.00%
BIIB - SNYNF
21%
Poorly correlated
-1.25%
OGN - SNYNF
17%
Poorly correlated
-0.30%
SCLX - SNYNF
7%
Poorly correlated
-7.13%
MIRA - SNYNF
4%
Poorly correlated
-2.42%
More